David joined the Oxford Vaccine Group in May 2018. He has a Ph. D in molecular biology from the University of Newcastle-Upon-Tyne. He conducted postdoctoral studies with the University of Oxford and the University of Nebraska Medical Center before Returning to Oxford. Following a spell as a researcher with the NHSBT he began clinical trial management in the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences before moving to OVG. David’s role in OVG is to work closely with the study team to ensure the delivery of projects on time, within budget and in compliance with regulatory requirements.
Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT.
Barker KL. et al, (2019), Health Technol Assess, 23, 1 - 318
Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture - A randomised controlled trial and economic evaluation (PROVE trial): ISRCTN 49117867
Barker K. et al, (2018), JOURNAL OF BONE AND MINERAL RESEARCH, 33, 21 - 21
Storage of washed or irradiated red cells in AS-7 improves their in vitro characteristics.
Proffitt S. et al, (2015), Vox Sang, 109, 203 - 213
Loss of Fibulin-2 Expression Is Associated with Breast Cancer Progression
Yi C-H. et al, (2007), The American Journal of Pathology, 170, 1535 - 1545
Metallothioneins and resistance to cisplatin and radiation in prostate cancer
Smith DJ. et al, (2006), Urology, 67, 1341 - 1347